Chi-Med’s fruquintinib gets approval for colorectal cancer in China
Hutchison China MediTech (Chi-Med) has secured approval from the National Medical Products Administration of China (NMPA) for the use of…
colorectal cancer
-
-
Array BioPharma’s mCRC therapy gets breakthrough status
Array BioPharma has received breakthrough therapy designation from the US Food and Drug Administration (FDA) to use encorafenib (Braftovi) in…
